MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
March 24, 2006
Rich Duprey
Honing In on Laserscope The medical-use laser manufacturer may get a boost from a laser deal with China. Investors, one deal does not a quarter make, but it could be signal that the tide is turning for this leading medical device laser manufacturer. mark for My Articles similar articles
The Motley Fool
June 6, 2006
S.J. Caplan
American Medical Greenlights a Merger The med-tech firm is well positioned to build on a strong market presence, and its price did drop yesterday. But near-term pains can best be avoided by not chasing this stock until both the financing terms of the Laserscope deal and the disposition of its aesthetics business are clarified. mark for My Articles similar articles
The Motley Fool
April 17, 2007
Rich Duprey
Foolish Forecast: A Bet Candela Can't Afford to Lose The aesthetic laser maker is set to report third-quarter 2007 financial results. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
January 10, 2006
Rich Duprey
Biolase Brightens Outlook The aesthetic laser company expects to be cash flow-neutral on flat revenues. Investors cheer. mark for My Articles similar articles
The Motley Fool
November 5, 2004
Rich Duprey
Profit From Management Integrity Laser manufacturer Candela's management avoids taking the easy way out to explain shortfalls. It's a sign of management integrity that will lead to future profits. mark for My Articles similar articles
Managed Care
February 2001
In Medicare Bill, HMOs Got What They Wanted When the dust cleared over how $35 billion in Medicare "givebacks" would be divided, the Republicans prevailed -- Medicare HMOs got a bigger cut than Democrats wanted to give them. Now, President Bush may be poised to give Medicare managed care plans more... mark for My Articles similar articles
The Motley Fool
July 1, 2011
Luke Timmerman
Dendreon Sways Medicare to Pay for Prostate Cancer Drug The decision by Medicare is no surprise, but it does conclude a period of uncertainty about insurance reimbursement for its lone marketed product. mark for My Articles similar articles
Managed Care
November 2001
Medicare+Choice Problems Chasing Away 58 Health Plans Medicare+Choice, the program that was supposed to ease the elderly into managed care, is itself suffering from the uneasiness of HMOs dissatisfied with payment rates... mark for My Articles similar articles